Schwartz Jeffrey Lawrence's Form 4 filing
SpringWorks Therapeutics, Inc. (SWTX) · filed Mar 20, 2023
- Accession no.
- 0000899243-23-009117
- Filed
- Mar 20, 2023
- Trade date
- Mar 16, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $49.9M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwartz Jeffrey LawrenceCIK 0001702957 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | Common Stock | SSaleDisposed | −1,750,000 | $28.50 | −$49,875,000 | 3,081,307 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.